Healthcare Market Research Reports
The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.
Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....
Key Topics Covered in Healthcare:
Drug Development & Innovation:
- Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
- Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
- Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
- Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.
Digital Health & Telehealth:
- Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
- Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
- Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
- Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
- Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.
Medical Devices & Diagnostics:
- Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
- Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
- Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
- Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
- Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
- Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
- Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
- Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
- Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
- Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
- Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.
Other Healthcare Growth Areas:
- Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
- Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.
Clinical Trials & Drug Development Services:
- Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
- Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.
Biopharmaceutical Products:
- Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
- Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.
For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.
-
19 Oct 2023  |  Global  |  Frost Radar
Frost Radar : Digital Biomarkers, 2023
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Digital biomarkers play a crucial role in early disease detection and prevention; data-driven insights generated by wearable support early diagnosis, real-time monitoring of patient health, precise healthcare delivery, remote patient monitoring, and advanced R&D effort in the treatment of neurodegenerative conditions. While innovation focuses on th...
$4,950.00 -
16 Oct 2023  |  Global  |  Frost Radar
Frost Radar™: Predictive Genetic Testing Technologies, 2023
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Predictive genetic testing (PGT) comprises analysis of genes, the whole genome, or exomes to predict the risk of a wide range of disorders. It can have long-term implications in preventive healthcare practices, including delayed onset of disease, treatment management, pharmacogenomics, and general wellness. One outcome of the COVID-19 pandemic has ...
$4,950.00 -
06 Oct 2023  |  Global  |  Frost Radar
Frost Radar™: Enterprise Cloud Imaging Informatics, 2023
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
The skyrocketing volume of medical imaging data and need to better manage medical images is becoming imperative for healthcare providers. The collaborative HIMSS-SIIM Enterprise Imaging Workgroup de?nes enterprise imaging as “a set of strategies, initiatives, and work?ows implemented across a healthcare enterprise to consistently and optimally ca...
$4,950.00 -
04 Aug 2023  |  Global  |  Market Outlook
2023 Growth Opportunity Outlook in the Women’s Health Industry
Evolving Technologies and Trends Drive a Healthier and More Inclusive Future
In recent years, there has been a remarkable surge of interest and investment in women's health and wellness, marking a profound shift toward prioritizing women’s health and empowerment worldwide. As women take center stage in various aspects of society, including leadership roles and decision-making processes, there is increasing recognition of ...
$2,450.00
Special Price $2,205.00 save 10 %
-
27 Jun 2023  |  Global  |  Frost Radar
Frost Radar™: Soft Tissue Navigation Systems, 2023
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Robot-assisted surgery offers significant promise in driving down treatment costs and addressing the healthcare industry’s increasing burden of lifestyle-related diseases and demand for affordable care. Next-generation surgical robotics technology and surgical navigation systems complement and extend surgeons’ ability to minimize surgical varia...
$4,950.00
Special Price $4,455.00 save 10 %
-
03 Apr 2023  |  Global  |  Market Outlook
Global Next generation Diagnostics, Outlook 2023
Automation and Digitization Drive the Next Growth Phase Post-COVID-19
As COVID-19 transitions to the endemic phase, automation solutions and smart, connected laboratories will catalyze recovery in the next-generation diagnostics industry. The COVID-19 pandemic left a lot of installed capacity in laboratories and healthcare centers. To take advantage of this situation, it is necessary for industry players to focus on ...
$4,950.00
Special Price $4,455.00 save 10 %
-
27 Mar 2023  |  Global  |  Market Outlook
Global Pharmaceutical Industry Outlook, 2023
Transformative Megatrends are Expanding the Vendor Ecosystem
This outlook identifies the trends shaping the global pharmaceutical landscape. The growth of the global pharmaceutical industry will plateau in 2023 due to a slowdown of the biologics segment as a result of a decrease in the uptake of COVID-19 vaccines and therapeutics. Market growth will be low in the United States and Europe and highest in the A...
$4,950.00
Special Price $4,455.00 save 10 %
-
09 Nov 2021  |  Global  |  Frost Radar
Frost Radar™: Global RNA Delivery Technologies, 2021
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
The year 2018 was a breakthrough period for RNA therapeutics as the first RNA therapy received approval from the FDA. In the wake of the COVID-19 pandemic, RNA vaccines have witnessed immense progress and acceptance globally. These events have contributed massively to growth across the RNA therapeutics market. Currently, several RNA therapeutic...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Jun 2021  |  Global  |  Frost Radar
Frost Radar™: Artificial Intelligence-enabled Drug Discovery in the Global Pharmaceutical Industry, 2021
A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines
Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...
$4,950.00
Special Price $3,712.50 save 25 %
-
09 Nov 2017  |  Global  |  Market Outlook
Healthcare Cloud Computing Outlook, Global, 2016–2021
Market Maturity on the Horizon as Cloud Enables New Care Delivery Models through PaaS and Hybrid Cloud Adoption
The global market for healthcare cloud computing—revenue generated by cloud computing services offered to providers—will be worth just under $10 billion by 2021 primarily driven by the need for storage of the exponentially increasing volume of healthcare data. However, volume is only the beginning of the story; healthcare data in rapidly increa...
$4,950.00
Special Price $3,712.50 save 25 %